Champions Oncology Reports $15.2M Revenue In Q1 Fiscal 2027
Oncology revenue rose 8.8% to $15.2 million, with oncology services margin improving to 51% and adjusted EBITDA increasing from $59,000 to $671,000 year-over-year.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day